Citius Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 9, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	64	170	99	-	-	-
Market Cap Growth	-2.41%	70.46%	-	-	-	-
Enterprise Value	64.71	169.41	103.26	0	0	0
Last Close Price	0.72	2.03	1.39	-	-	-
PB Ratio	1.90	3.78	2.16	-	-	-
P/TBV Ratio	1.72	3.32	2.05	-	-	-
P/FCF Ratio	-	-	787.14	-	-	-
P/OCF Ratio	-	-	787.14	-	-	-
EV/FCF Ratio	-	-	817.22	-	-	-
Debt / Equity Ratio	0.11	0.08	0.08	0	0	-
Debt / FCF Ratio	-	-	30.08	-	-	-
Net Debt / Equity Ratio	0.03	0.00	0.08	-	-0.84	-
Net Debt / EBITDA Ratio	-0.03	0.01	-0.18	-	2.09	-
Net Debt / FCF Ratio	-0.07	0.02	30.07	-	6.03	-
Quick Ratio	0.06	0.08	0.00	0	9.08	-
Current Ratio	0.50	0.56	0.34	0.37	11.85	-
Return on Equity (ROE)	-90.75%	-54.42%	-59.01%	-98.12%	220.43%	-
Return on Assets (ROA)	-41.87%	-26.52%	-32.02%	-21.91%	-0.41%	-
Return on Invested Capital (ROIC)	-44.17%	-23.63%	-26.13%	-19.93%	-0.41%	-
Return on Capital Employed (ROCE)	-81.24%	-45.62%	-52.51%	-25.56%	-0.41%	-
FCF Yield	-	-	0.13%	-	-	-
Buyback Yield / Dilution	-20.32%	-7.66%	-2798.38%	-25.87%	-8.14%	-
Total Shareholder Return	-20.32%	-7.66%	-2798.38%	-25.87%	-8.14%	-

SEC Filings: 10-K · 10-Q